BECTON DICKINSON & CO
BDX
DELAYED 1 MONTH

11 insider filings · Latest: Jul 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 27, 2026Jul 28 3:16 PMMichael FeldEVP, Chief Revenue Officer
Sale
75$157.13$11.8K20,934(D)

View →

Jun 10, 2026Jun 11 9:21 PMMichael David GarrisonEVP & Pres Med.Essntl&BioPharm
Sale
1,100$151.48$166.6K14,272(D)

View →

Jun 1, 2026Jun 3 4:44 PMThomas E Polen JrDirector, Chairman, CEO and President
Sale
2,764$146.35$404.5K110,163(D)

View →

May 26, 2026May 27 5:41 PMMichael FeldEVP, Chief Revenue Officer
Sale
75$147.35$11.1K21,084(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 1, 2026Jun 3 4:44 PMThomas E Polen JrDirector, Chairman, CEO and President
Option Exercise
20,209—0(D)

View →

May 8, 2026May 8 9:26 PMRobert Luther HuffinesDirector
Grant/Award
210—404(D)

View →

May 8, 2026May 8 9:25 PMCarrie L ByingtonDirector
Grant/Award
105—3,699(D)

View →